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A B S T R A C T   
Blood-contacting medical devices play an important role within healthcare and are required to be biocompatible, 
hemocompatible and resistant to microbial colonization. Here we describe a high throughput screen for co-
polymers with these specific properties. A series of weakly amphiphilic monomers are combinatorially poly-
merized with acrylate glycol monomers of varying chain lengths to create a library of 645 multi-functional 
candidate materials containing multiple chemical moieties that impart anti-biofilm, hemo- and immuno- 
compatible properties. These materials are screened in over 15,000 individual biological assays, targeting two 
bacterial species, one Gram negative (Pseudomonas aeruginosa) and one Gram positive (Staphylococcus aureus) 
commonly associated with central venous catheter infections, using 5 different measures of hemocompatibility 
and 6 measures of immunocompatibililty. Selected copolymers reduce platelet activation, platelet loss and 
leukocyte activation compared with the standard comparator PTFE as well as reducing bacterial biofilm for-
mation in vitro by more than 82% compared with silicone. Poly(isobornyl acrylate-co-triethylene glycol meth-
acrylate) (75:25) is identified as the optimal material across all these measures reducing P. aeruginosa biofilm 
formation by up to 86% in vivo in a murine foreign body infection model compared with uncoated silicone.   
1. Introduction 
Blood-contacting medical devices, such as vascular catheters and 
venous access ports, are routinely used in healthcare settings [1,2]. Such 
devices should be biocompatible, hemocompatible, and resistant to 
surface-initiated blood coagulation processes and adverse immune re-
actions [3]. However, devices such as central venous catheters (CVCs) 
are associated with unacceptably high levels of treatment complications 
including occlusion, thrombosis and infection. Typically, 
catheter-related bloodstream infections (CRBSIs) are the most frequent, 
lethal, and costly complications observed. In the US alone, an estimated 
quarter of a million CVC-associated infections are responsible for over 
30,000 preventable deaths per year [4–6]. 
Once inserted into the vasculature, biomaterial surfaces become 
rapidly coated with a blood conditioning film triggering a complex 
series of closely interlinked events which lead to protein adsorption, 
platelet and leukocyte adhesion/activation, complement activation, 
coagulation and thrombosis [7,8]. Activation of the complement and 
blood clotting cascades drive inflammatory and thrombotic reactions 
including the generation of anaphylatoxins, such as complement C3a, 
C5a and bradykinin, thrombin from prothrombin, and the activation of 
leukocytes and platelets [9], which can collectively cause serious harm 
to the patient via heart attack or stroke [10,11]. 
Blood conditioning also impacts on infecting micro-organisms colo-
nising the device either immediately following implantation or via he-
matogenous spread during bacteremia. Common bacterial pathogens 
causing CVC-associated infections include Gram positives such as 
Staphylococcus aureus and Staphylococcus epidermidis and Gram negatives 
including Pseudomonas aeruginosa and Klebsiella pneumoniae [12]. 
Although many different microbial pathogens are capable of forming 
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biofilms on unconditioned CVC surfaces, their coating with blood pro-
teins such as fibrinogen provides additional options for adherence via 
specific bacterial cell surface receptors that facilitate attachment and 
subsequent biofilm formation [13,14]. For example, pathogens such as 
Staphylococcus aureus can generate an extracellular matrix from the 
coagulase-dependent conversion of fibrinogen to fibrin [15]. Biofilm 
formation promotes bacterial survival by shielding infecting pathogens 
from host immune defences and reducing their susceptibility to anti-
microbial agents. Furthermore, the emergence of multi-antibiotic 
resistant pathogens constitutes a global threat to patient well-being 
[16]. Thus, generating resistance to bacterial colonization and biofilm 
development within complex, blood contact environments continues to 
pose a challenging problem for the biomedical device field. New ap-
proaches that reduce the incidence of infection and aid promotion of 
antibiotic stewardship are required in order to improve patient 
outcomes. 
Loading medical devices with antimicrobial agents has had limited 
success in mitigating infections, largely due to depletion during use, 
passivation due to biomolecular adsorption or toxicity [17–21]. Mate-
rials that have a molecular structure that inherently resists bacterial 
biofilm formation by preventing bacterial attachment and/or subse-
quent biofilm development offer an alternative approach. To date, a 
number of different surface chemistries have been explored including 
low-fouling surfaces such as poly(ethylene glycol) (PEG) [22], zwitter-
ionic based materials [23–26] and weakly amphiphilic polyacrylates 
employing hydrocarbon side chains [27–29]. However, despite some 
promising in vitro and in vivo testing successes in animal infection 
models, clinical efficacy has yet to be demonstrated with respect to 
infection prevention in blood contacting environments. Thus, there re-
mains a need for the discovery of novel materials that are both resistant 
to biofilm formation and hemocompatible. 
High throughput screening approaches have been applied to discover 
polymeric materials with desirable biological properties including for 
stem cell culture [30–32], antimicrobial properties [33] and prevention 
of bacterial biofilm formation [28]. Here we describe a screen for hemo- 
and immune-compatible copolymers capable of resisting bacterial bio-
film formation by employing a multifaceted high throughput microarray 
screening methodology (Fig. 1) [34,35]. Selected hits were scaled up for 
further in vitro and in vivo analysis for selection of an optimal 
hemo-compatible, anti-biofilm material. 
2. Results and discussion 
2.1. Array preparation 
We selected a series of weakly amphiphilic monomers from a library 
of 16 acrylates and methacrylates (Figure SI1, 1-16) that had previously 
been shown to resist biofilm formation when polymerized [27–29,36], 
and have also been shown to permit the permeation of antimicrobials for 
the creation of dual-functional anti-biofilm and anti-microbial coatings 
[37]. Since PEG based materials have been widely studied for their 
ability to prevent fouling by both blood proteins and host cells [22], 
monomers 1–16 were each combinatorially mixed with acrylate glycol 
monomers of varying chain lengths (Figure SI1, A-D) at volume ratios of 
100:0 (homopolymers), 75:25, 50:50, 25:75 and 0:100 and copoly-
merized. Zwitterionic polymers have also been proposed as bacter-
ial/protein resistant and hemocompatible materials, thus suitable 
monomers were included on the array for comparison (Figure SI1, E-G) 
[24,25]. Together, PEG and zwitterionic materials are representative of 
the broad class of highly hydrophilic anti-fouling materials. In contrast, 
Fig. 1. An overview of polymer microarray screening and scale up of ‘hit’ material compositions for in vitro and in vivo testing. (a) Polymer microarray printing using 
a robotic contact printer on pHEMA coated round and rectangular slides. (b) Quasi-static and flow chambers used for human whole blood incubation. (c) (i) 
Quantification of platelet, leukocyte, fibrinogen, IgG, complement C3a binding/adsorption to each microarray polymer spot after 2 h incubation with whole blood; 
(ii) Incubation of microarrays conditioned in blood for 2 h with P. aeruginosa or S. aureus. (d) Confocal microscope images showing surface bacterial coverage of the 
lead ‘hit’ material coated onto silicone catheter compared to commercially available silver and uncoated silicone catheters; evaluation of haemostasis and 
inflammation markers on scaled up hit materials. (e) Coating of scaled up ‘hit’ compositions on silicone catheters (confirmed by SEM) and in-vivo testing of lead 
material in a murine foreign body infection model. 
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the weakly amphiphilic monomers are relatively hydrophobic (water 
contact angles 70–80), but also resist bacterial biofilm formation via an 
anti-attachment mechanism that does not rely upon bacterial killing 
[28]. The combined monomer solutions were printed in triplicate on a 
single poly(hydroxy ethyl methacrylate) (pHEMA) coated glass slide for 
biofilm assays and a single array was printed onto a pHEMA coated 
coverslip for the hemocompatibility assay (Fig. 1a). After printing the 
monomers were irradiated with UV light to initiate polymerisation via a 
photo-initiator that had been included in the formulation to generate a 
polymer microarray with 645 unique materials. 
2.2. Hemocompatibility and biofilm screen 
To obtain an in vitro assessment of hemocompatibility for all 645 
polymers, the polymer microarray was incubated with whole human 
blood for 2 h in quasi-static conditions, with no external flow applied to 
the sample but where the sealed vessels were placed on a rotating 
platform to avoid blood sedimentation (Fig. 1b). Each polymer spot was 
then analysed to determine platelet adhesion, fibrinogen, IgG and 
complement adsorption and leukocyte attachment as a preliminary 
measure of potential hemo- and immune-compatibility (Figure SI2). 
The total amount of the adsorbed protein layer was quantified on 
each polymer by XPS (quantified based on surface nitrogen composition 
[38]) (Figure SI2a). Copolymers of triEGMA exhibited the lowest protein 
adsorption whereas the material with the lowest protein adsorption of 
0.2 nm was poly (isobornyl acrylate (iBnA) (25%):triEGMA (75%)). In 
contrast, copolymers of butyl methacrylate (BuMA), hexyl acrylate (HA) 
and hexyl methacrylate (HMA) exhibited thicker protein layers, with the 
polymer poly(HA (75%):triEGMA (25%) exhibiting the highest protein 
adsorption of 2.5 nm. 
Platelet adhesion (Figure SI2b), a key step in supporting the blood 
clotting cascade, was an order of magnitude (102 vs 7.1  103 AU) less 
than the platelet adhesion measured on polytetrafluoroethylene (PTFE; 
Teflon) for all polymers assessed. PTFE is commonly used as a 
comparator for platelet adhesion and overall hemocompatibility and is 
used to make vascular grafts due to its low surface energy [39]. Reduced 
platelet adhesion was observed on copolymers of methyl ether termi-
nated poly(ethylene glycol) methacrylate monomers (H3C-PEGMA). 
Higher adhesion was observed on copolymers of decylmethacrylate 
(DMA) and iBnA. However, the highest platelet adhesion observed on 
any of polymers was on a poly(norbornyl methacrylate copolymer (i.e. 
(NMA) (50%): HO-PEGMA (50%)). For all criteria assessed the acrylates 
with hydrocarbon pendant groups present on the microarray out-
performed the low-fouling PEG and zwitterionic materials tested. This 
suggests that we had identified a polymer sub-library composed of 
materials with low-fouling or anti-biofilm properties with significant 
potential for use in blood contacting environments. It is important to 
note that the performance of PEG and zwitterionic materials is depen-
dent on their conformation and, therefore, the fabrication process [40]. 
It is likely that the preparation of these materials by in-situ polymeri-
sation did not produce the optimal conformation (ie brush structure) to 
achieve high level anti-fouling performance. Furthermore, a key aspect 
of this study was the selection of polymeric formulations, the production 
of which could be readily scaled to quantities required for the industrial 
manufacture of medical devices. This was previously achieved for the 
prevention of bacterial biofilm using a simple and scalable polymeri-
sation approach. Coatings produced from this material are performing 
well clinically as coatings for urinary tract catheters [41,42]. This gives 
confidence that scale-up of ‘hit’ formulations from the present screen 
would result in similar biological performance as was measured on the 
array format. 
Fibrinogen adsorption was also assessed as a precursor to 
biomaterial-induced thrombosis and because it is targeted by S. aureus 
strains that express fibrinogen-binding proteins [15]. Reduced fibrin-
ogen adsorption was observed on numerous polymers compared with 
the PEGMA and zwitterionic controls in Figure SI2c. Copolymers of 
DMA, iBnA, trimethylcyclohexyl methacrylate (tMCHMA) and DEGMA 
all exhibited low fibrinogen adsorption. In the case of DMA and iBnA, 
the low fibrinogen adsorption contrasted with the higher platelet 
adhesion seen in Figure SI2b. 
As an assessment of the adherence of blood immune system com-
ponents, leukocyte attachment, IgG adsorption and C3b adsorption to 
the different polymers was quantified. Reduced adhesion of both leu-
kocytes and IgG was observed on copolymers of DEGMA and triEGMA 
compared with HO-PEGMA and H3C-PEGMA (Figure SI2d-e). In 
contrast, the lowest C3b adsorption was observed for the homopolymer 
of HO-PEGMA and its associated copolymers (Figure SI2f). Copolymers 
of BuMA, iDMA and NMA also exhibited low C3b adsorption whereas 
the zwitterionic materials exhibited relatively high levels of C3b 
adsorption in comparison with the poly(ethylene glycol) (PEG)-based 
materials. 
The suitability of a polymer for blood contacting medical devices 
relates not only to bio-, immuno- and hemo-compatibility, but also to its 
resistance to microbial colonization and subsequent biofilm formation. 
Consequently, we selected both a Gram negative (Pseudomonas aerugi-
nosa) and a Gram positive (S. aureus) pathogen known to cause difficult 
to treat CVC-related bloodstream infections for high throughput 
screening [17,18]. Both these bacterial species are multi-antibiotic 
resistant ESKAPE pathogens listed by the World Health Organisation 
as posing the greatest risk to human health [43]. Increased bacterial 
biofilm formation was observed for both species on silicone and silver 
hydrogel coated catheters after blood conditioning (Figure SI3a). Poly-
mer microarrays were incubated for 2 h in whole blood under static 
conditions prior to incubation with each fluorescently labelled pathogen 
(Fig. 1c). Intensity maps of the resulting fluorescence measurements are 
shown in Fig. 2a–b, where the most promising biofilm resistant materials 
were copolymers with 25% triEGMA or DEGMA. The hits for each 
bacterial species is shown in Figure SI3b and c. 
With the exception of the homopolymer of HMA with P. aeruginosa, 
all the DEGMA or triEGMA copolymer formulations outperformed their 
homopolymer counterparts for both bacterial species. Addition of 25% 
(v/v) DEGMA or triEGMA to copolymer formulations improved the 
overall ability of the resulting polymer to resist biofilm formation. 
However, increasing the DEGMA/triEGMA content to 75% (v/v) 
generally reduced biofilm resistance (Fig. 2a–b). Furthermore, while the 
zwitterionic polymer sulfobetaine methacrylate (SBMA) exhibited high 
resistance to P. aeruginosa, the weakly amphiphilic polymers out-
performed both the PEG and zwitterionic controls in reducing S. aureus 
biofilm formation. The primary action of these acrylate polymers does 
not involve killing as very little growth inhibition is observed when the 
bacteria are cultured in contact with the polymer [28]. 
P. aeruginosa and S. aureus biofilm formation on the homopolymers 
of the ethylene glycol monomers increased with increasing chain length; 
the lowest biofilm levels were observed on poly(DEGMA). The highest 
bacterial biofilm coverage for both species was observed on poly(H3C- 
PEGMA), with biofilm levels observed to be significantly (p < 0.024) 
higher than on poly(HO-PEGMA) for both bacterial species. This sug-
gested that a hydroxyl terminal group on a PEG chain resisted bacterial 
biofilm formation more effectively than a methyl group for a blood 
conditioned sample. This may be attributable to differences in hydro-
phobicity and/or chain conformation that, in turn, modulate the 
composition of adsorbed blood cell/protein conditioning layer [44]. 
Although the overall protein layer on poly(HO-PEGMA) was thicker 
than on poly(H3C-PEGMA) (2.11 nm compared with 1.32 nm; 
Figure SI2b), less fibrinogen was adsorbed. This suggests that the 
identity of an adsorbed protein on a surface, rather than the amount 
present is the key to determining how much biofilm forms on a material. 
This is consistent with the greater level of biofilm formed on 
H3C-PEGMA by S. aureus compared with P. aeruginosa given that the 
latter lacks specific fibrinogen receptors. 
For 15 of the 16 monomers tested, biofilm formation was reduced by 
the addition of short chain glycol monomers, with lower bacterial 
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fluorescence values observed for the DEGMA or triEGMA copolymers 
(except at 75%), when compared with the associated homopolymer 
(Fig. 2a and b). Thus, it was hypothesised that the mechanism by which 
the weakly amphiphilic acrylates resist bacterial attachment is different 
to that of the PEG alternatives. This conclusion was supported by the 
observation that they exhibited very different affinities for water as 
indicated by their higher water contact angles [27]. The enhanced 
resistance to biofilm formation achieved by combining the two mono-
mer types suggests a synergistic combination of two distinct mecha-
nisms, which likely includes modulating the composition of the proteins 
adsorbed during blood-conditioning. 
Each of the eight different result sets from the microarray data were 
assessed for linear correlations by measuring the coefficient of deter-
mination (R2) (Figure SI3d). Correlations where R2 > 0.3 are shown in 
Figure SI4. A linear correlation was observed between the attachment of 
both bacterial species to the materials library (R2  0.55, Figure SI4a), 
consistent with previous studies [28]. The highest correlation between 
two datasets across the entire polymer library was the level of fibrinogen 
and IgG adsorption (R2  0.75). An association between fibrinogen 
adsorption and an immunological response has been previously 
observed [45], and enhanced adsorption of fibrinogen in the presence of 
IgG has also been reported [46]. However, previous comparisons of 
fibrinogen and IgG adsorption from blood plasma onto varied surface 
coatings did not reveal a strong correlation [47,48]. However, the pol-
yacrylates contained in the polymer microarrays within this study have 
molecular structures significantly different to the plasma polymer films 
and poly(vinyl alcohol) membranes studied previously. This suggests 
that the correlation between fibrinogen and IgG adsorption observed in 
these studies may be limited to the chemical space represented by the 
polymer microarrays. The absence of a correlation between platelet 
Fig. 2. High throughput biological screening of the polymer library and selection of hits. (a-b) Intensity map representations of fluorescence readouts (au) of biofilm 
formation on each polymer spot on the microarray for a) P. aeruginosa and b) S. aureus. c) Intensity scale of fluorescence values compiling a subset of biological 
measurements taken for 6 selected ‘hit’ copolymers (first 6 formulations listed), demonstrating the biofilm resistance and hemocompatibility of hit materials across 
the multiple parameters assessed (biofilm formation (a and b), leukocyte attachment, IgG adsorption, platelet adhesion and fibrinogen adsorption). Measurements for 
the entire polymer library are shown in Figure SI2. Values for control non-fouling materials and 2 materials with poor biological performance are also shown. d) 
Intensity scale used for intensity maps. e) The numerical high and low values (au) for each biological screen. f) The chemical structures of the monomers used to 
make the ‘hit’ copolymer formulations. The structures of all monomers used in the study are shown in Figure SI1. 
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attachment or C3b adsorption and any of the other biological parame-
ters studied suggests that these processes occur independently of the 
biological systems being investigated [49]. Only a weak correlation 
between leukocyte attachment and IgG adsorption was observed. This 
contrasted with findings of previous literature studies, which reported 
that fibrinogen, rather than IgG, promoted leukocyte adhesion [50,51] 
although differences in the conformation of adsorbed proteins that may 
influence cellular interactions cannot be ruled out [11]. 
Bacterial attachment also correlated weakly (R2  0.3–0.5) with 
leukocyte attachment, IgG and fibrinogen adsorption but not with pro-
tein thickness, C3b adsorption and platelet adhesion (Figure SI3d). 
These results are consistent with the evidence that specific blood com-
ponents rather than protein layer thickness are the defining parameters 
for biofilm formation on these polymers. S. aureus for example has 
multiple cell wall receptors for fibrinogen (e.g. ClfA, ClfB, FnbpA) and 
IgG [52]. 
Monomers with branched long chain hydrocarbon moieties, such as 
iDMA and EHA, featured frequently within the low biofouling material 
compositions. This suggests that, within the pendant groups of the 
polymers, the molecular rigidity associated with cyclic structures is less 
important for preventing bacterial attachment to the blood conditioned 
polymer surfaces, when compared with previous work conducted in 
protein free media [29]. However, some cyclic monomers, such as iBnA, 
also contributed to materials with both low blood component adsorption 
and resistance to bacterial biofilm formation. 
The fluorescence (F) values for both bacterial species for each blood 
exposed polymer were averaged to provide a measure of combined 
bacterial resistance to biofilm formation. The copolymer with the 
greatest overall resistance was poly(trimethylhexyl acrylate(75%): 
DEGMA(25%)) with an average F value of 0.016 au. This was similar to 
the F value observed on both p(HO-PEGMA) (F  0.162) and three 
zwitterionic polymers (i.e. sulfobetaine methacrylamide, sulfobetaine 
methacrylate and phosphorylcholine methacrylate) F  0.142–0.203 
au), suggesting that for this assay, the copolymer more effectively 
reduced biofilm formation than the common control anti-fouling poly-
mers. Meanwhile, by exhibiting an F  0.841 au, poly(isodecyl 
Fig. 3. Blood clotting and immune system activation by scaled up selected copolymer formulations under flow ( ) and quasi-static ( ) conditions. a) List of materials. 
All monomer acronyms are listed in Figure SI1. (b-f) Blood clotting mediator assays: b) platelet activation measured by platelet factor 4 (PF4), c) fibrinogen 
adsorption, d) coagulation activation measured by prothrombin fragment 1  2 (F12), e) platelet decay assay, f) leukocyte-platelet conjugate assay, (g-l) immune 
component activation assays to assess: g) complement activation measured as complement C5a, h) leukocyte activation assay using granulocyte CD11b marker 
normalized to lipopolysaccharide, i) leukocyte loss assay, j) surface leukocyte density, k) IgG surface adsorption, l) complement C3b surface adsorption. Error bars 
equal 1 standard deviation unit (n  3). Statistical comparison of measurement shown in Fig. 4 and Figure SI5. 
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methacrylate) (iDMA) (25%):methyl terminated poly(ethylene glycol) 
methacrylate(H3C-PEGMA) (75%)), was the material with the highest 
overall biofilm formation for both bacterial species. 
2.3. Hit selection 
Polymer formulations were selected for further study by considering 
the combination of both their bacterial biofilm resistance and blood 
component adsorption microarray data (Fig. 2 and SI2). The six hit 
formulations initially selected alongside control samples are listed in 
Fig. 2c, together with an intensity scale showing the respective values 
for each material relative to each biological parameter quantified. All hit 
formulations offered low biological responses for all parameters (i.e. >
83% reduction compared with the highest response measured). How-
ever, two copolymers that exhibited the lowest responses to all biolog-
ical parameters were poly(iDMA(75%): diethylene glycol methyl ether 
methacrylate (DEGMA) (25%)) and poly(norbornyl methacrylate 
(75%): tri(ethylene glycol) methacrylate (triEGMA) (25%)). Copolymers 
containing the short chain glycols (DEGMA and triEGMA) exhibited 
overall low biological parameters when compared with those containing 
the PEGMA monomers. Therefore, only DEGMA and triEGMA co-
polymers were selected for further evaluation. Copolymers were 
selected in preference to homopolymers, as the homopolymers typically 
were brittle due to relatively high glass transition temperatures that 
were lowered after the addition of a co-monomer (associated with the 
inclusion of glycol monomers), which improved material flexibility 
[42]. 
2.4. In vitro assessment of scaled-up hit formulations 
Since the polymer microarray format is unsuitable for in vitro in-
vestigations of the activation of blood clotting and inflammatory me-
diators, the synthesis of promising hemocompatible and biofilm 
resistant copolymers was scaled-up to approximately 100 g quantities 
using thermally-induced catalytic chain transfer polymerisation [42]. 
The resulting materials were characterized by gel permeation chroma-
tography (GPC) and nuclear magnetic resonance (NMR) (Figure SI6-11 
and Table SI1). The isolated and purified product copolymers were 
dip-coated onto class coverslips to form thin films. This sample format 
allowed the assessment of ‘hit’ materials without the influence of 
neighbouring spots. Blood clotting and immune system activation assays 
(Fig. 1d) on the scaled-up copolymers were carried out under both 
quasi-static (Figure SI12) and flow conditions (Figure SI13) as the shear 
stress induced by blood flow can cause conformational changes in blood 
proteins that promote protein adhesion and blood clotting [53]. No vi-
sual evidence of delamination was observed and in all cases the coatings 
were observed to be present after biological assays. Platelet activation 
and loss (Fig. 3b and e) were the only blood clotting parameters affected 
by flow where the introduction of shear stress markedly increased the 
responses observed. Leukocyte-platelet conjugate formation, quantified 
by flow cytometry via the thrombocyte-specific surface marker CD41a, 
is a useful measure of surface-mediated coagulation and immune system 
activation [7,54]. For this assay, the behaviour of the six copolymer 
formulations matched that of Teflon AF (Fig. 3f). 
As an assessment of immune system activation, leukocyte, comple-
ment and IgG assays were conducted on the 6 selected copolymers in 
both flow and static conditions (Fig. 3g–l). As a general trend, all of the 
surfaces investigated displayed higher complement C5a release and 
leukocyte activation (CD11b) under flow (Fig. 3g–h). Copolymers poly 
(ethylhexyl acrylate(EHA) (75%): tri(ethylene glycol) methacrylate 
(triEGMA) (25%)) and poly(isodecyl acrylate (iDMA) (75%):diethylene 
glycol methyl ether methacrylate (DEGMA) (25%)) exhibited increased 
C5a release (2.7 and 2.4 fold higher, respectively) under flow but not 
under static conditions compared with Teflon AF (Fig. 3g). Each of the 
copolymers showed minimal leukocyte loss (Fig. 3i) comparable with 
that of Teflon AF whereas leukocyte density was higher under static 
conditions compared to flow conditions for the majority of surfaces 
tested (Fig. 3j). Surface IgG and complement assays produced more 
variable results with three copolymers showing a comparable response 
and three showing low surface IgG adsorption compared with Teflon AF 
(Fig. 3k–l). 
Notably, all materials except poly(NMA-co-DEGMA) (75:25) offered 
a significant (p < 0.05) reduction in platelet activation compared with 
Teflon, while poly(iBnA-co-triEGMA) (75:25) also produced a signifi-
cant (p < 0.05) reduction in platelet loss. When comparing with all other 
polymers, poly(iBnA-co-triEGMA) (75:25) induced signifcantly less 
leukocyte activation and exhibited lower numbers of surface associated 
leukocytes whilst poly(EHA-co-triEGMA) (75:25) was responsible for 
significantly less leukocyte loss, although this polymer caused signifi-
cantly higher complement activation. Poly(NMA-co-DEGMA) (75:25) 
exhibited signficantly lower numbers of surface associated leukocytes. 
When the measured parameters were directly compared (Fig. 4), 
poly(isobornyl acrylate (iBnA)-co-triEGMA) (75:25) achieved overall 
the lowest thrombogenic and immune/inflammatory responses as the 
only material showing a statistically significant reduction in platelet 
activation, platelet loss and leukocyte activation compared with PTFE. 
The 6 lead materials were coated onto catheter sections (ca. 50 μm 
thick, Figure SI14) and assessed in in vitro bacterial biofilm assays with 
P. aeruginosa and S. aureus after blood pre-conditioning for 2 h as a 
model of the initial fouling expected on devices after insertion into the 
body (Fig. 1d). Bacterial biofilm coverage was quantified by confocal 
microscopy and image analysis (Figure SI15). All of the copolymer 
formulations exhibited substantially lower bacterial surface coverage 
than uncoated silicone or commercial silver coated catheter segments, 
the materials currently used clinically. Poly(iBnA-co-triEGMA) (75:25) 
showed the lowest level of biofilm formation for both pathogens, 5.5 
2.8% and 15.1  4.4%, respectively, corresponding to an overall 
reduction of 93% and 82% compared with the uncoated silicone cath-
eter (Figure SI15). This result compares favourably with the 97% 
reduction in bacterial attachment reported in the literature in the 
absence of blood conditioning using the best material from that study; 
poly(ethylene glycol dicyclopentenyl ethyl acrylate-co-DEGMA(74:26)) 
[28]. Thus, the combination of two monomers with different but com-
plementary properties was able to produce a multi-functional material 
that was both hemocompatible, immunocompatible and resistant to 
bacterial biofilm formation after exposure and potential fouling by 
blood components. This material makes use of the anti-fouling proper-
ties of ethylene glycol moieties [22], whilst also preserving the 
anti-biofilm properties of iBnA. In the case of the weakly amphiphilic 
iBnA monomer, although the mechanism by which this class of mono-
mers prevents bacterial biofilm formation has not been not fully eluci-
dated, it is likely to involve a combination of bacterial sensing of the 
material surfaces and the physicochemical factors in the near-surface 
environment, which in this case depend on the action of bulky ester 
linked hydrophobic pendant groups [29,36]. Live/dead staining of 
bacterial biofilm grown on the hit polymer compared with silicone 
showed primarily live cells on both surfaces with a clear reduction in 
biofilm formation on the former consistent with its biofilm inhibitory 
properties (Figure SI16). Furthermore, as the coating required no 
leachable component in order to achieve resistance to bacterial biofilm 
formation, it is expected to have increased longevity of activity if clin-
ically applied compared with coatings that rely on the delivery of anti-
microbials such as silver. 
2.5. In vivo assessment 
Given the favourable in vitro biological properties of the iBnA-co- 
triEGMA polymer, we investigated its performance in vivo in a murine 
foreign body (FB) infection model (Fig. 1e). Poly iBnA-co-triEGMA 
(75:25) coated catheter segment FBs were inserted subcutaneously 
and inoculated with either a bioluminescent P. aeruginosa or S. aureus 
strain and the progress of infection followed over time via quantitative 
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whole live animal imaging. Metabolically active bacteria at the infection 
site were quantified via their light output each day for 4 days post- 
inoculation (Fig. 5 and Figure SI17). Afterwards the mice were eutha-
nized, the implants were removed, imaged and then subjected to his-
tological analysis of the surrounding tissues (Fig. 6). In the live animals, 
P. aeruginosa exhibited greater than an order of magnitude reduction in 
luminescence after one day for the coated samples compared with the 
uncoated samples that persisted for the duration of the experiment 
(Fig. 5). In contrast to the silicone implants, metabolically active 
P. aeruginosa bacteria failed to seed into the tissues surrounding the poly 
iBnA-co-triEGMA (75:25) coated FBs (Fig. 5a day 4 ex vivo) or colonize 
the coated implant itself (Fig. 5 day 4, FB). 
To examine the qualitative impact of the host response to the 
copolymer and silicone implants, the tissues from un-infected and 
infected sites surrounding the implanted catheter segments were excised 
and stained histologically for the host cellular response and presence of 
bacterial cells. Fig. 6 shows evidence of fibroblast-mediated collagen 
deposition in the tissues surrounding the implant sites for both PDMS 
and the copolymer in both un-infected and infected samples. This was 
indicative of a foreign body response and tissue repair. Importantly, the 
poly iBnA-co-triEGMA (75:25) coated polymer samples in common with 
PDMS and consistent with the in vitro blood contact immune assays did 
not activate an immune response (Fig. 6a and b). A strong cellular im-
mune response was clearly apparent in the tissues of mice infected with 
P. aeruginosa (Fig. 6c and d) as shown by the high level of lectin-staining 
of immune cells and fibroblasts recruited to the tissues surrounding the 
implants. However, in contrast to the PDMS implant, no bacteria were 
present in the tissue samples surrounding the copolymer (Fig. 6 compare 
c and d, combined staining) consistent with the bioluminescence data 
and the anti-biofilm properties of poly iBnA-co-triEGMA (75:25)). 
Although promising in vitro data for S. aureus (Figure SI15) on blood 
conditioned poly(iBnA-co-triEGMA) was obtained, staphylococcal 
colonization in vivo was similar for both coated and uncoated catheter 
segments sustaining high luminescence over 4 days (Figure SI17). This is 
consistent with biofilm formation and resistance to immune clearance 
despite the activation of a robust host response (Fig. S18). Since foreign 
body responses are associated with the formation of a dense collagen 
matrix [3], this may be attributable, in part, to the ability of S. aureus to 
bind host tissue proteins such as collagen deposited during host FB re-
sponses (e.g. Fig. 6 and S18, collagen stain) via specific bacterial surface 
receptors [52]. 
3. Conclusions 
In summary, an in vitro multifaceted polymer microarray screen has 
been developed to discover materials that are hemocompatible, mini-
mally activate the host immune system and refractory to bacterial bio-
film formation. Selected copolymers were demonstrated to maintain 
reduced blood clotting cascade and immune system activation as well as 
resistance to biofilm formation in vitro. The best performing material in 
vitro, poly(iBnA(75%); triEGMA(25%)), reduced P. aeruginosa biofilm 
formation by up to 86% in vivo compared with uncoated silicone after 4 
days. The data presented highlight the potential of this material as a 
blood contacting biomaterial that prevents biofilm-centred infections 
associated with vascular access devices. 
4. Experimental section 
Materials: Monomers were purchased from Sigma Aldrich and sol-
vents from Fisher Scientific UK respectively and used as received 
without further purification. All the copolymer ratios defined in this 
manuscript are v/v ratios. 
Polymer Microarrays: Polymer microarrays were prepared as previ-
ously described [28]. Monomers 1–16 were mixed with glycol mono-
mers at ratios of 1:0, 3:1, 1:1, 1:3 and 0:1 (v/v). The combined monomer 
solutions were printed in triplicate as approximately 400 μm diameter 
spots with a height of ~10 μm. A total of 20 replicate arrays of 645 
materials were typically prepared in 6–10 h. 
Coverslip Dip coating: Epoxy functionalised glass slides (Arrayit) were 
dip coated with 6% w/v pHEMA in 19:1 ethanol:water (v/v) 4 times in 
Fig. 4. Statistical analysis (student’s t-test) of blood clotting cascade and immune system activation measurements on scaled up selected copolymer formulations 
under flow and quasi-static conditions. Individual datasets shown in Fig. 3. Squares coloured blue or red indicate samples where a significant (p < 0.05) decrease or 
increase was observed, respectively, compared to PTFE (comparison with other polymers is shown in Figure SI5). Grey squares indicate no significant difference. 
Squares coloured white were due to an error in the measurement acquisition for a particular sample. Flow or static conditions are indicated. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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sequence with a withdrawal speed of 2 mm/s and 10 min drying be-
tween dips using a dip coater (HO-TH-01, Holmarc, India). Coatings 
were kept in ambient conditions at room temperature prior to testing. 
XPS Analysis: X-ray photoelectron spectroscopy (XPS) was conducted 
using a Kratos Axis Ultra spectrometer with a mono-chromated 
Aluminium X-ray gun (AlKα  1253.6 eV) and a charge-compensating 
electron flood gun. Photoelectrons were sampled from a 110 μm diam-
eter (aperture) in the centre of each polymer spot in snapshot mode for 
the C1s, N1s and O1s core levels. The acquisition time was limited to 30 
s for N1s and 20 s for C1s and O1s scans, using a pass energy of 160 eV. 
Data analysis was carried out using CASA XPS software (version 2.3.16 
PR 1.6). 
Catalytic chain transfer polymerisation: Bis[(difluoroboryl) diphenyl-
glyoximato] cobalt(II) (100 mg, DuPont) and 2,20-azobis(4methoxy-2,4- 
dimethyl valeronitrile) (240 mg, Sigma) were added to a 500 ml flask 
containing argon. In a typical experiment to prepare a 75%:25% v/v 
polymer, 75.2 ml of the major monomer, 20.8 ml of minor monomer and 
200 ml of toluene were added to the flask. The subsequent reaction 
solution was then degassed by bubbling with argon for 30 min. The 
reaction mixture was then raised to and held at 80 C for 18 h with 
stirring. The polymerisation was terminated by cooling the contents to 
room temperature and exposure to air with rapid stirring. The polymer 
was precipitated in cold methanol and isolated by filtration or decanting 
the solvent, depending on the physical form of the resultant polymer, 
before drying under vacuum. 
NMR Analysis: - 1H NMR spectroscopic analyses were recorded at 25 
C using Bruker DPX-300 and AV-400 MHz spectrometers in toluene-d8 
or deuterated chloroform (CDCl3) (1 mg ml-1) to which chemical shifts 
were referenced (residual toluene at 2.09 ppm and chloroform at 7.26 
ppm). Analysis of the spectra was carried out using ACDLABS 12 
software. 
GPC Analysis: GPC was carried out at a solvent flow at 1 ml min  1. A 
7 mg ml  1 polymer solution in tetrahydrofuran was injected to the GPC 
system by an autosampler through a series of three columns: one PLgel 5 
μm Guard column (Polymer Laboratories) and then two PLgel 5 μm 
MIXED-C columns (Polymer Laboratories), which were kept at 35 C. 
After separation, the polymer fractions were analysed by an IR detector. 
SEM Analysis: Coating thickness was assessed by scanning electron 
microscopy (SEM). Coated samples were plunged into liquid nitrogen 
and fractured using a scalpel blade. Samples were sputter coated with 
gold for 4 min using a Leica EM SCD005 support coater and imaged 
using a JEOL 6060LV variable pressure SEM. 
Catheter Section Dip Coating: Rusch Brilliant Paediatric silicone 
catheters (Teleflex Medical) size 8 F R, 3 ml and 31 cm length were cut 
into 1 cm lengths. Samples were activated by O2 plasma at 50 W power 
and 300 mTorr working pressure for 10 min in a custom built reactor 
[55]. Catheter pieces were dip coated with 30% w/v polymer solution 
(in DCM) using a dip coater (HO-TH-01, Holmarc, India) before drying 
under vacuum (<50 mbar) for seven days. 
Bacterial Strains and Growth Media: The bacterial pathogens used 
were P. aeruginosa PAO1-L and Staphylococcus aureus SH1000. These 
were labelled with either fluorescent proteins or rendered biolumines-
cent by the introduction of bacterial luciferase (lux) genes. The mCherry 
(pMMR; tetracycline resistant) [56] and mKat (pBS10 -mKat plasmid 
(erythromycin resistant)) [57] expression vectors were transformed into 
P. aeruginosa and S. aureus, respectively, by electroporation and main-
tained on LB agar plates containing tetracycline (125 μg/ml) or eryth-
romycin (30 μg/ml). 
Biofilm assays: For assays of biofilm formation on microarray slides 
and catheter segments, bacteria were grown overnight in RPMI-1640 
medium at 37 C with shaking at 200 rpm after which the cells were 
harvested by centrifugation. Bacteria were resuspended to an optical 
density at 600 nm (OD600) of 0.01 in 15 ml fresh RPMI-1640 containing 
either a microarray slides or uncoated silicone or coated catheter seg-
ments previously incubated for 2 h with human blood as described. The 
cultures were incubated at 37 C with shaking at 60 rpm for 72 h. Slides 
and catheter segments were washed once with PBS and once with 
deionized water before imaging. Microarrays were imaged using a 
Fig. 5. Murine foreign body (FB) infection with P. aeruginosa for testing the in vivo performance of the ‘hit’ copolymer. a) Luminescent images of the implantation site 
in live mice over 4 days for uncoated and iBnA-co-triEGMA (75:25) polymer coated silicone catheter segments inoculated with bioluminescent P. aeruginosa. The FBs 
were implanted subcutaneously. Light output from bacteria colonizing the implanted co-polymer coated segments in whole live mice was measured on days 0–4. 
After the mice were euthanized, the catheter segments were removed and both the surrounding tissues (day 4, ex vivo) and the implants (day 4, FB) imaged ex vivo. 
Inset: intensity scale (radiance) where red and blue refer to high and low light outputs respectively. Image dimensions  16  16 mm. b) Quantification of light 
output (normalized radiance) from uncoated silicone (red) and poly(iBnA-co-triEGMA) polymer coated catheter segments (blue) for P. aeruginosa. Error bars show 
one standard deviation unit, N  8. Significant differences (Student’s unpaired t-test) are indicated as *  p < 0.1, **  p < 0.05 and ***p < 0.01. (For interpretation 
of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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Genepix 4200AL fluorescence scanner (Molecular Devices UK Ltd.) 
using an excitation wavelength of 594 nm and emission filter set at 
607–694 nm. Image processing was conducted using Genepix Pro 6.1 
software (Molecular Devices UK Ltd.). Catheter segments were imaged 
by confocal fluorescence microscopy (Zeiss LSM 710) and biofilm sur-
face coverage calculated using the ImageJ plugin, Comstat 2.1 [58]. 
Live/dead staining was carried out using a LIVE/DEAD™ BacLight™ 
Bacterial Viability Kit (Molecular Probes) as per the manufacturer’s 
instructions. 
Whole blood incubation assay: The phlebotomy work was carried out 
in the Clinical Research Facility, School of Medicine based at Queens 
Medical Centre, Nottingham University Hospitals as per ethical approval 
(Ref: BT09052014 SoP SoLS, Faculty of Medicine and Health Sciences 
Research Ethics Committee). When using the static cell, microarrays 
were assembled as top and bottom of autoclaved quasi-static incubation 
chambers made of PTFE, with printed side facing inwards (Figure SI12). 
Each incubation chamber held 1.95 ml blood with a surface to volume 
ratio of 3.2 cm  1 [59]. The incubation chambers were filled with 0.9% 
NaCl solution and allowed to equilibrate at 37 C prior to whole blood 
exposure. For the flow cell, samples were assembled into the flow cell as 
depicted in Figure SI13. Blood was incubated at a shear rate of 300 s  1 
using a spacer of 150 μm. 
Venous blood was obtained using a 19G cannula from two healthy 
volunteers with no known medical conditions and who had not taken 
any medication 10 days prior to blood donation, with 3 repeats taken for 
each volunteer. Blood clotting was prevented by addition of 2 (static) or 
4 (dynamic) IU/ml heparin and immediately used to fill incubation 
chambers (pre-warmed to 37 C), avoiding air bubbles in the chambers. 
Samples were incubated for 2 h at 37 C. Following incubation, blood 
was drained and the slides washed twice with PBS and once with 
deionized water. 
For leukocyte and platelet detection experiments, samples were 
incubated in 2% paraformaldehyde in phosphate buffered saline (PBS) 
for 1 h followed by a PBS wash. Leukocyte detection was carried out 
using a DNA-staining dye Sytox Green (1 μM) with 0.05% Saponin 
(30–60 min). Surface attached platelets were detected using mouse anti- 
human CD41a FITC (FACS-antibody, Becton Dickinson) 1:10 in blocking 
buffer (2% dry milk powder, 0.05% Tween-20 in PBS). 
For fibrinogen, IgG and complement C3b detection, samples were 
incubated in blocking buffer for 30 min. Rabbit anti-human fibrinogen 
(FITC) (Cedarlane) 1:30 in blocking buffer was used to detect fibrinogen 
by incubating for 1 h. Goat anti-human IgG (Rhodamine Red X) (Jackson 
Immuno) 1:50 in blocking buffer was used to detect IgG. Rabbit (rb) 
anti-human C3b 1:500 (primary antibody) and anti-rb IgG (Alexa 488) 
1:200 (secondary antibody) were used to detect C3b. 
Complement fragment C5a, prothrombin fragment F12 and 
platelet factor 4 (PF4) were assessed by ELISA (C5a micro, DRG In-
struments, Marburg, Germany; Enzygnost F12 micro, Siemens, 
Eschborn, Germany; Zymutest PF4, CoaChrom, Vienna, Austria, 
respectively) according to the manufacturers’ instructions. Blood cell 
counts were determined with a cell counter ACT diff (Beckman coulter, 
Krefeld, Germany). CD11b expression on granulocytes and monocytes 
and platelet leukocyte conjugate formation were assessed by flow 
cytometry in a lyse-no-wash protocol (anti CD11b clone ICRF44, Biozol, 
Eching, Germany, and anti CD41a, (clone HIP8, Becton Dickinson, 
Heidelberg, Germany; cytometer FACSCalibur, Becton-Dickinson, 
Fig. 6. Histological analysis of tissue sections surrounding subcutaneously implanted silicone (a, c) and poly (iBnA-co-triEGMA) catheter segments (b, d) recovered 
from a-b) control (uninfected) mice and c-d) mice infected with P. aeruginosa. Tissue sections were stained from left to right with hematoxylin and eosin (general 
tissue morphology), Masson’s trichome (collagen*), combined (all 5 stains), DNA (DAPI), lipids (FM1-163) and lectins (wheat germ lectin-Alexa 680 conjugate). Of 
particular note is the high level of lectin reactive staining (red) in the 2 lower righthand panels for c-d indicative of a strong cellular immune response due to the 
presence of bacteria compared with the sterile upper two right hand control panels (a–b). The insets in the ‘combined’ panel images show localized bacterial foci (c, 
white arrow) only in the infected mice with silicone implants. (d). There was reduced infiltration of reactive fibroblasts and immune cells to the sterile sites compared 
with the infection sites. Scale bar equals 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of 
this article.) 
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Heidelberg, Germany). 
Fluorescence measurements were performed using a Fujifilm FLA- 
5100 fluorescence scanner. 
In vivo mouse infection experiments: All animal work was approved 
following ethical review at the University of Nottingham and performed 
under U.K Home Office licence 30/3238. The murine foreign body 
model was conducted as described previously [28] where mice were 
implanted subcutaneously with either silicone or poly 
(iBnA-co-triEGMA) coated catheter segments. Animals were allowed to 
recover for 4 days prior to inoculation with 1  105 constitutively 
bioluminescent S. aureus (strain SH1000) or P. aeruginosa (strain PAO1-L 
CTX:tac-lux) respectively into the lumen of longitudinally bisected 
catheter segments (2.6 mm  4.2 mm x 7.5 mm). Injection of the bac-
teria into the lumen ensured that the inoculum was contained proximal 
to the catheter surface aiding uniformity of infection levels between 
each mouse and experiment. Mice were imaged under anesthesia using 
an IVIS spectrum camera (Caliper) after the initial bacterial inoculation 
to provide a readout of infection level for normalization, and then at 24 
h intervals. Infection was tracked over 4 days by assessment of light 
output for the localization of metabolically active bacteria at the 
infection site. At day 4 mice were humanely killed and the catheter 
segment and surrounding tissue harvested. The catheter was then 
excised from the tissue and the localization of metabolic bacteria 
determined for both the tissue and the catheter. 
Histological assessment of infection site tissues: Tissues excised from the 
infection sites were fixed by incubation in 10% formal saline for 24 h, 
and then processed for paraffin embedding. 8 μm sections were stained 
for the evaluation of tissue morphology using hematoxylin and eosin 
staining. Collagenesis was assessed using Masson’s trichrome (light 
green; Atom-scientific RRSK21-500). The localization of glycoproteins 
induced via the host innate immune response to infection was deter-
mined using a wheat germ agglutinin (WGA)-Alexa 680 conjugate 
(Thermofisher), incubated 5 μg/ml for 1 h at 37 C, washed twice PBS 
and then stained for DNA and lipids using DAPI (5 μg/ml) and FM-143 
(5 μg/ml) for 10 min and mounted with Fluoromount (Sigma-Aldrich). 
Images were taken on a Zeiss 700 confocal microscope. 
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